Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

AtriCure Inc

Current price
34.14 USD +0.71 USD (+2.12%)
Last closed 32.99 USD
Sector Healthcare
Industry Medical Instruments & Supplies
Exchange NASDAQ
Capitalization 1 733 238 784 USD
Yield for 12 month -19.75 %
21.11.2021 - 28.11.2021

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio. Address: 7555 Innovation Way, Mason, OH, United States, 45040


WallStreet Target Price

55 USD

P/E ratio

Dividend Yield

6.21 %

Current Year

+330 379 000 USD

Last Year

+274 329 000 USD

Current Quarter

+98 290 000 USD

Last Quarter

+100 918 000 USD

Current Year

+245 940 000 USD

Last Year

+205 860 000 USD

Current Quarter

+73 869 000 USD

Last Quarter

+77 077 000 USD

Key Figures ATRC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -8 598 000 USD
Operating Margin TTM -8.23 %
PE Ratio
Return On Assets TTM -2.34 %
PEG Ratio -1.18
Return On Equity TTM -5.44 %
Wall Street Target Price 55 USD
Revenue TTM 380 729 984 USD
Book Value 9.77 USD
Revenue Per Share TTM 8.25 USD
Dividend Share
Quarterly Revenue Growth YOY 18.1 %
Dividend Yield 6.21 %
Gross Profit TTM 245 940 000 USD
Earnings Share -0.54 USD
Diluted Eps TTM -0.54 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin -6.52 %

Dividend Analytics ATRC

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ATRC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield 6.21 %
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ATRC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 4.3984
Price Sales TTM 4.5524
Enterprise Value EBITDA -395.0458
Price Book MRQ 3.7448

Financials ATRC

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators ATRC

For 52 weeks

32.27 USD 59.61 USD
50 Day MA 38.54 USD
Shares Short Prior Month 1 373 078
200 Day MA 44.12 USD
Short Ratio 3.67
Shares Short 1 621 292
Short Percent 3.52 %